Home Healthcare Biotechnology Biomarkers Market

Biomarkers Market Size, Share & Trends Analysis Report By Type (Safety, Efficacy, Validation), By Application (Diagnostics, Drug Discovery & Development, Personalized Medicine, Others), By Disease (Cancer, Cardiovascular Diseases, Neurological Diseases, Immunological Diseases, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: April 22, 2026 | Author: Mitiksha Koul | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Biomarkers Market, By Type 2022-2034 (USD MILLION/ Units)
    1. Safety
    2. Efficacy
    3. Validation
  2. Biomarkers Market, By Application 2022-2034 (USD MILLION/ Units)
    1. Diagnostics
    2. Drug Discovery & Development
    3. Personalized Medicine
    4. Others
  3. Biomarkers Market, By Disease 2022-2034 (USD MILLION/ Units)
    1. Cancer
    2. Cardiovascular Diseases
    3. Neurological Diseases
    4. Immunological Diseases
    5. Others
  4. Regional Biomarkers Market
    1. North America
      1. North America Biomarkers Market By Type 2022-2034 (USD MILLION/ Units)
        1. Safety
        2. Efficacy
        3. Validation
      2. North America Biomarkers Market By Application 2022-2034 (USD MILLION/ Units)
        1. Diagnostics
        2. Drug Discovery & Development
        3. Personalized Medicine
        4. Others
      3. North America Biomarkers Market By Disease 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Cardiovascular Diseases
        3. Neurological Diseases
        4. Immunological Diseases
        5. Others
      4. U.S.
        1. Safety
        2. Efficacy
        3. Validation
        4. Diagnostics
        5. Drug Discovery & Development
        6. Personalized Medicine
        7. Others
        8. Cancer
        9. Cardiovascular Diseases
        10. Neurological Diseases
        11. Immunological Diseases
        12. Others
      5. Canada
        1. Safety
        2. Efficacy
        3. Validation
        4. Diagnostics
        5. Drug Discovery & Development
        6. Personalized Medicine
        7. Others
        8. Cancer
        9. Cardiovascular Diseases
        10. Neurological Diseases
        11. Immunological Diseases
        12. Others
    2. Europe
      1. Europe Biomarkers Market By Type 2022-2034 (USD MILLION/ Units)
        1. Safety
        2. Efficacy
        3. Validation
      2. Europe Biomarkers Market By Application 2022-2034 (USD MILLION/ Units)
        1. Diagnostics
        2. Drug Discovery & Development
        3. Personalized Medicine
        4. Others
      3. Europe Biomarkers Market By Disease 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Cardiovascular Diseases
        3. Neurological Diseases
        4. Immunological Diseases
        5. Others
      4. U.K.
        1. Safety
        2. Efficacy
        3. Validation
        4. Diagnostics
        5. Drug Discovery & Development
        6. Personalized Medicine
        7. Others
        8. Cancer
        9. Cardiovascular Diseases
        10. Neurological Diseases
        11. Immunological Diseases
        12. Others
      5. Germany
        1. Safety
        2. Efficacy
        3. Validation
        4. Diagnostics
        5. Drug Discovery & Development
        6. Personalized Medicine
        7. Others
        8. Cancer
        9. Cardiovascular Diseases
        10. Neurological Diseases
        11. Immunological Diseases
        12. Others
      6. France
        1. Safety
        2. Efficacy
        3. Validation
        4. Diagnostics
        5. Drug Discovery & Development
        6. Personalized Medicine
        7. Others
        8. Cancer
        9. Cardiovascular Diseases
        10. Neurological Diseases
        11. Immunological Diseases
        12. Others
      7. Spain
        1. Safety
        2. Efficacy
        3. Validation
        4. Diagnostics
        5. Drug Discovery & Development
        6. Personalized Medicine
        7. Others
        8. Cancer
        9. Cardiovascular Diseases
        10. Neurological Diseases
        11. Immunological Diseases
        12. Others
      8. Italy
        1. Safety
        2. Efficacy
        3. Validation
        4. Diagnostics
        5. Drug Discovery & Development
        6. Personalized Medicine
        7. Others
        8. Cancer
        9. Cardiovascular Diseases
        10. Neurological Diseases
        11. Immunological Diseases
        12. Others
      9. Russia
        1. Safety
        2. Efficacy
        3. Validation
        4. Diagnostics
        5. Drug Discovery & Development
        6. Personalized Medicine
        7. Others
        8. Cancer
        9. Cardiovascular Diseases
        10. Neurological Diseases
        11. Immunological Diseases
        12. Others
      10. Nordic
        1. Safety
        2. Efficacy
        3. Validation
        4. Diagnostics
        5. Drug Discovery & Development
        6. Personalized Medicine
        7. Others
        8. Cancer
        9. Cardiovascular Diseases
        10. Neurological Diseases
        11. Immunological Diseases
        12. Others
      11. Benelux
        1. Safety
        2. Efficacy
        3. Validation
        4. Diagnostics
        5. Drug Discovery & Development
        6. Personalized Medicine
        7. Others
        8. Cancer
        9. Cardiovascular Diseases
        10. Neurological Diseases
        11. Immunological Diseases
        12. Others
      12. Rest of Europe
        1. Safety
        2. Efficacy
        3. Validation
        4. Diagnostics
        5. Drug Discovery & Development
        6. Personalized Medicine
        7. Others
        8. Cancer
        9. Cardiovascular Diseases
        10. Neurological Diseases
        11. Immunological Diseases
        12. Others
    3. APAC
      1. APAC Biomarkers Market By Type 2022-2034 (USD MILLION/ Units)
        1. Safety
        2. Efficacy
        3. Validation
      2. APAC Biomarkers Market By Application 2022-2034 (USD MILLION/ Units)
        1. Diagnostics
        2. Drug Discovery & Development
        3. Personalized Medicine
        4. Others
      3. APAC Biomarkers Market By Disease 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Cardiovascular Diseases
        3. Neurological Diseases
        4. Immunological Diseases
        5. Others
      4. China
        1. Safety
        2. Efficacy
        3. Validation
        4. Diagnostics
        5. Drug Discovery & Development
        6. Personalized Medicine
        7. Others
        8. Cancer
        9. Cardiovascular Diseases
        10. Neurological Diseases
        11. Immunological Diseases
        12. Others
      5. Korea
        1. Safety
        2. Efficacy
        3. Validation
        4. Diagnostics
        5. Drug Discovery & Development
        6. Personalized Medicine
        7. Others
        8. Cancer
        9. Cardiovascular Diseases
        10. Neurological Diseases
        11. Immunological Diseases
        12. Others
      6. Japan
        1. Safety
        2. Efficacy
        3. Validation
        4. Diagnostics
        5. Drug Discovery & Development
        6. Personalized Medicine
        7. Others
        8. Cancer
        9. Cardiovascular Diseases
        10. Neurological Diseases
        11. Immunological Diseases
        12. Others
      7. India
        1. Safety
        2. Efficacy
        3. Validation
        4. Diagnostics
        5. Drug Discovery & Development
        6. Personalized Medicine
        7. Others
        8. Cancer
        9. Cardiovascular Diseases
        10. Neurological Diseases
        11. Immunological Diseases
        12. Others
      8. Australia
        1. Safety
        2. Efficacy
        3. Validation
        4. Diagnostics
        5. Drug Discovery & Development
        6. Personalized Medicine
        7. Others
        8. Cancer
        9. Cardiovascular Diseases
        10. Neurological Diseases
        11. Immunological Diseases
        12. Others
      9. Taiwan
        1. Safety
        2. Efficacy
        3. Validation
        4. Diagnostics
        5. Drug Discovery & Development
        6. Personalized Medicine
        7. Others
        8. Cancer
        9. Cardiovascular Diseases
        10. Neurological Diseases
        11. Immunological Diseases
        12. Others
      10. South East Asia
        1. Safety
        2. Efficacy
        3. Validation
        4. Diagnostics
        5. Drug Discovery & Development
        6. Personalized Medicine
        7. Others
        8. Cancer
        9. Cardiovascular Diseases
        10. Neurological Diseases
        11. Immunological Diseases
        12. Others
      11. Rest of Asia-Pacific
        1. Safety
        2. Efficacy
        3. Validation
        4. Diagnostics
        5. Drug Discovery & Development
        6. Personalized Medicine
        7. Others
        8. Cancer
        9. Cardiovascular Diseases
        10. Neurological Diseases
        11. Immunological Diseases
        12. Others
    4. Middle East and Africa
      1. Middle East and Africa Biomarkers Market By Type 2022-2034 (USD MILLION/ Units)
        1. Safety
        2. Efficacy
        3. Validation
      2. Middle East and Africa Biomarkers Market By Application 2022-2034 (USD MILLION/ Units)
        1. Diagnostics
        2. Drug Discovery & Development
        3. Personalized Medicine
        4. Others
      3. Middle East and Africa Biomarkers Market By Disease 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Cardiovascular Diseases
        3. Neurological Diseases
        4. Immunological Diseases
        5. Others
      4. UAE
        1. Safety
        2. Efficacy
        3. Validation
        4. Diagnostics
        5. Drug Discovery & Development
        6. Personalized Medicine
        7. Others
        8. Cancer
        9. Cardiovascular Diseases
        10. Neurological Diseases
        11. Immunological Diseases
        12. Others
      5. Turkey
        1. Safety
        2. Efficacy
        3. Validation
        4. Diagnostics
        5. Drug Discovery & Development
        6. Personalized Medicine
        7. Others
        8. Cancer
        9. Cardiovascular Diseases
        10. Neurological Diseases
        11. Immunological Diseases
        12. Others
      6. Saudi Arabia
        1. Safety
        2. Efficacy
        3. Validation
        4. Diagnostics
        5. Drug Discovery & Development
        6. Personalized Medicine
        7. Others
        8. Cancer
        9. Cardiovascular Diseases
        10. Neurological Diseases
        11. Immunological Diseases
        12. Others
      7. South Africa
        1. Safety
        2. Efficacy
        3. Validation
        4. Diagnostics
        5. Drug Discovery & Development
        6. Personalized Medicine
        7. Others
        8. Cancer
        9. Cardiovascular Diseases
        10. Neurological Diseases
        11. Immunological Diseases
        12. Others
      8. Egypt
        1. Safety
        2. Efficacy
        3. Validation
        4. Diagnostics
        5. Drug Discovery & Development
        6. Personalized Medicine
        7. Others
        8. Cancer
        9. Cardiovascular Diseases
        10. Neurological Diseases
        11. Immunological Diseases
        12. Others
      9. Nigeria
        1. Safety
        2. Efficacy
        3. Validation
        4. Diagnostics
        5. Drug Discovery & Development
        6. Personalized Medicine
        7. Others
        8. Cancer
        9. Cardiovascular Diseases
        10. Neurological Diseases
        11. Immunological Diseases
        12. Others
      10. Rest of MEA
        1. Safety
        2. Efficacy
        3. Validation
        4. Diagnostics
        5. Drug Discovery & Development
        6. Personalized Medicine
        7. Others
        8. Cancer
        9. Cardiovascular Diseases
        10. Neurological Diseases
        11. Immunological Diseases
        12. Others
    5. LATAM
      1. LATAM Biomarkers Market By Type 2022-2034 (USD MILLION/ Units)
        1. Safety
        2. Efficacy
        3. Validation
      2. LATAM Biomarkers Market By Application 2022-2034 (USD MILLION/ Units)
        1. Diagnostics
        2. Drug Discovery & Development
        3. Personalized Medicine
        4. Others
      3. LATAM Biomarkers Market By Disease 2022-2034 (USD MILLION/ Units)
        1. Cancer
        2. Cardiovascular Diseases
        3. Neurological Diseases
        4. Immunological Diseases
        5. Others
      4. Brazil
        1. Safety
        2. Efficacy
        3. Validation
        4. Diagnostics
        5. Drug Discovery & Development
        6. Personalized Medicine
        7. Others
        8. Cancer
        9. Cardiovascular Diseases
        10. Neurological Diseases
        11. Immunological Diseases
        12. Others
      5. Mexico
        1. Safety
        2. Efficacy
        3. Validation
        4. Diagnostics
        5. Drug Discovery & Development
        6. Personalized Medicine
        7. Others
        8. Cancer
        9. Cardiovascular Diseases
        10. Neurological Diseases
        11. Immunological Diseases
        12. Others
      6. Argentina
        1. Safety
        2. Efficacy
        3. Validation
        4. Diagnostics
        5. Drug Discovery & Development
        6. Personalized Medicine
        7. Others
        8. Cancer
        9. Cardiovascular Diseases
        10. Neurological Diseases
        11. Immunological Diseases
        12. Others
      7. Chile
        1. Safety
        2. Efficacy
        3. Validation
        4. Diagnostics
        5. Drug Discovery & Development
        6. Personalized Medicine
        7. Others
        8. Cancer
        9. Cardiovascular Diseases
        10. Neurological Diseases
        11. Immunological Diseases
        12. Others
      8. Colombia
        1. Safety
        2. Efficacy
        3. Validation
        4. Diagnostics
        5. Drug Discovery & Development
        6. Personalized Medicine
        7. Others
        8. Cancer
        9. Cardiovascular Diseases
        10. Neurological Diseases
        11. Immunological Diseases
        12. Others
      9. Rest of LATAM
        1. Safety
        2. Efficacy
        3. Validation
        4. Diagnostics
        5. Drug Discovery & Development
        6. Personalized Medicine
        7. Others
        8. Cancer
        9. Cardiovascular Diseases
        10. Neurological Diseases
        11. Immunological Diseases
        12. Others
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.